Current Treatment of Acquired Immune Deficiency Syndrome

College of Fisheries and Life Science, Dalian ocean university, Dalian, 116023, China

^* Corresponding author: dmayer72528@student.napavalley.edu

Abstract

Infection with the human immunodeficiency virus (HIV) has grown to be an important humanitarian problem influencing people worldwide. After a long period of research and practice, antiretroviral therapy (ART) and immunotherapy have gradually become the two main methods of treating HIV. However, there are still many questions to be explored regarding the comparison of these two treatments and the future direction of their development. Therefore, the aim of this study was to compare ART therapy and immunotherapy in HIV treatment and to explore their differences in terms of viral suppression, immune recovery, and patient quality of life. The potential and challenges of these two treatments in the future are envisioned.A thorough literature review and analysis were used to thoroughly assess research advancements in immunotherapy and antiretroviral therapy. ART entails long-term medication compliance and runs the risk of developing drug resistance. Immunotherapy has a lot of potential for inducing the immune system to manufacture particular antibodies and cellular immunological responses, but research is still being done to determine its usefulness and safety. The effectiveness of antiretroviral medication in preventing HIV infection and preserving patients’ health has been astounding, but issues with long-term drug use and drug resistance need to be addressed. While immunotherapy, a young science, presents prospects to create novel treatments, more study is required to guarantee their efficacy.Future HIV treatment may take advantage of both ideologies’ strengths to create a more effective combination therapy strategy with the ultimate objective to enhance HIV control and elimination.